Key learnings from COVID-19 vaccine development: Power of cross-industry collaboration and need for ethnic diversity in clinical trials 10-Feb-2021 By Jane Byrne Collaboration is not an unknown in the domain of pharmaceutical development, but it is rare enough. The demands of the COVID-19 pandemic, however, have seen competitors switch to become manufacturing allies.
